In this study, we set out to understand the prognostic significance of MSI-1 expression in breast cancer and subsequently investigated ramifications of targeting MSI-1 for apoptosis and therapy resistance in hormone receptor-positive breast cancer cells. Here, MSI1 is linked to breast carcinoma.